All In MedTech

Device Trial Radar · NCT02379923

The Asahi Intecc PTCA Chronic Total Occlusion Study

Last checked: Nov 20, 2026Latest source record: Jul 18, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

163

Actual

Start

Jun 2015

Primary completion

Jan 2016

Study completion Jan 2016

Sponsor

Lead sponsor
Asahi Intecc USA IncNot on our public-company list
Sponsor type
Industry
Collaborators
Medpace, Inc.
First posted
Mar 5, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this trial is to evaluate confirmation of placement of any guidewire beyond the chronic total occlusion (CTO) in the true vessel lumen in patients in which at least one Asahi series of guidewires and/or Corsair microcatheter were used. Procedure success will be defined as angiographic visualization of any guidewire in a position either distal or proximal to the occlusion depending on the route of access and the absence of in-hospital major adverse cardiac events (MACE).

Conditions

  • Coronary Artery Disease
  • Coronary Artery Chronic Total Occlusion

Interventions

  • Crossing of Coronary Artery CTODevice

    Standard angiographic procedures will be followed for this study. The primary objective of this trial is to evaluate confirmation of placement of any guidewire beyond the chronic total occlusion (CTO) in the true vessel lumen in patients in which at least one Asahi series of guidewires and/or Corsair microcatheter were used. Procedure success will be defined as angiographic visualization of any guidewire in a position either distal or proximal to the occlusion depending on the route of access and the absence of in-hospital MACE. Other Name: ASAHI Corsair Microcatheter, ASAHI PTCA Guide Wires

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Procedure SuccessTime frame: Through hospital discharge, typically 24 hours post procedure

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • Banner - University Medical Center Phoenix

    Phoenix, Arizona

11 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.